TrialAmerican journal of hematology2015

Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory acute lymphoblastic leukemia.

Tapan M Kadia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.